Evidence map›Paper›PMID 22822350›Full record

ReviewMarine drugs2012

Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.

Guadalupe-Miroslava Suarez-Jimenez, Armando Burgos-Hernandez, Josafat-Marina Ezquerra-Brauer

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 271 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The Contribution of Human Antimicrobial Peptides to Fungi.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Bioactive Peptides from Marine Organisms.Protein and peptide letters · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Bioactive peptides for anticancer therapies.Biomaterials translational · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Anti-lung Cancer Marine Compounds: A Review.Therapeutic innovation & regulatory science · 2022
    Review
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Guadalupe-Miroslava Suarez-JimenezDepartment of Research and Food Science Graduate Program, University of Sonora, Apartado Postal 1658, Hermosillo, Sonora, Mexico.
Armando Burgos-HernandezDepartment of Research and Food Science Graduate Program, University of Sonora, Apartado Postal 1658, Hermosillo, Sonora, Mexico.
Josafat-Marina Ezquerra-BrauerDepartment of Research and Food Science Graduate Program, University of Sonora, Apartado Postal 1658, Hermosillo, Sonora, Mexico.
Universidad de Sonora · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biologically active compounds with different modes of action, such as, antiproliferative, antioxidant, antimicrotubule, have been isolated from marine sources, specifically algae and cyanobacteria. Recently research has been focused on peptides from marine animal sources, since they have been found as secondary metabolites from sponges, ascidians, tunicates, and mollusks. The structural characteristics of these peptides include various unusual amino acid residues which may be responsible for their bioactivity. Moreover, protein hydrolysates formed by the enzymatic digestion of aquatic and marine by-products are an important source of bioactive peptides. Purified peptides from these sources have been shown to have antioxidant activity and cytotoxic effect on several human cancer cell lines such as HeLa, AGS, and DLD-1. These characteristics imply that the use of peptides from marine sources has potential for the prevention and treatment of cancer, and that they might also be useful as molecular models in anticancer drug research. This review focuses on the latest studies and critical research in this field, and evidences the immense potential of marine animals as bioactive peptide sources.

Indexed as

AnimalsAntineoplastic AgentsAquatic OrganismsBiological ProductsCell Line, TumorDepsipeptidesHeLa CellsHumansPeptidesAntineoplastic AgentsBiological ProductsDepsipeptidesPeptidesanticancerantiproliferativebioactive peptidemarine compounds

Identifiers

PMID22822350
PMCPMC3397454
OpenAlexW2004364256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.